BioWorld Science

June 15, 2005

View Archived Issues

CNS-5161 induces analgesic effects in patients with chronic neuropathic pain

Read More

Novel gene therapy for chronic pain targets glia / News in Context

Read More

Specific class II HDAC inhibitors for beta-thalassemia and sickle cell anemia treatment

Read More

KR-32570 improves functional and metabolic dysfunction post-ischemia

Read More

Neurocrine reviews pipeline progress

Read More

ISIS-301012 improves the lipid profile of patients with hypercholesterolemia

Read More

New data on the pharmacokinetics of dabigatran etexilate in humans

Read More

Acarbose shows promise in the treatment of renal disease

Read More

Phase II study under way with VX-702 for rheumatoid arthritis

Read More

Phase I study for Tarvacin in refractory advanced solid tumors

Read More

Cell Therapeutics sells Trisenox to Cephalon

Read More

Silodosin enters phase III in U.S. for BPH

Read More

Renovis ends phase Ia study of REN-850

Read More

FDA approves Adacel vaccine

Read More

Exelixis in transaction to fund development of drug candidates

Read More

Exelixis grants license to XL-119 to Helsinn Healthcare

Read More

U.S. Navy submits IND for Hemopure trauma trial

Read More

FDA agrees to rolling NDA for Virulizin

Read More

Non-approvable letter for Velac

Read More

AG-041R induces chondrogenesis via TGF-beta induction and MAPK activation

Read More

Dopamine D2 receptor ligands from Pfizer

Read More

Recent patents disclose novel treatments for HIV infection

Read More

New treatment options for respiratory and allergic disorders disclosed in recent patents

Read More

Low-dose PARP inhibitor combination therapy effective in early peripheral diabetic neuropathy

Read More